Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

31. März 2022 16:05 ET | Quelle: CV Sciences, Inc.

CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results

SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
12. August 2021 16:05 ET | Quelle: CV Sciences, Inc.

CV Sciences, Inc. Reports Second Quarter 2021 Financial Results

SAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
10. März 2021 07:00 ET | Quelle: CV Sciences, Inc.

CV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021

SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
08. Dezember 2020 07:00 ET | Quelle: CV Sciences, Inc.

CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction

SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
29. Juli 2020 08:00 ET | Quelle: CV Sciences, Inc.

CV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product Line

SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today...
30. April 2020 16:05 ET | Quelle: CV Sciences, Inc.

CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2020

SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
16. März 2020 16:05 ET | Quelle: CV Sciences, Inc.

CV Sciences, Inc. Reports Fiscal Year-End 2019 Financial Results

SAN DIEGO, March 16, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
26. Februar 2020 08:00 ET | Quelle: CV Sciences, Inc.

CV Sciences, Inc. to Announce Full Year 2019 Results on March 10, 2020

SAN DIEGO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
23. Januar 2020 08:45 ET | Quelle: CV Sciences, Inc.

CV Sciences, Inc. Launches Updated +PlusCBD™ Oil Website to Enhance User Experience and Drive Increased E-Commerce Sales

Refreshed Website Guides Visitors on their Hemp CBD Journey with Multimedia Educational Resources, In-Depth Product Information and Improved Shopping Tools Company Well Positioned to Drive Rapid...
21. Januar 2020 08:45 ET | Quelle: CV Sciences, Inc.

Farmers Insurance Open Selects +PlusCBD™ Oil as Their First-Ever CBD Sponsor

SAN DIEGO, Jan. 21, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc (OTCQB: CVSI) (the “Company”, “we” or “our”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its...

Nächste Seite